Shanqiang Qu

14PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer cell biologyHaematological tumoursPharmacogenomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 26, 2026
Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular Classification.

Shanqiang Qu, Qiuming Pan, Xin Zhang

|Dec 08, 2025
Integrating Single-Cell and Spatial Transcriptomics Reveals NK Cell Subpopulations Associated With Immunotherapy for Melanoma.

Zhicheng Hu, Yongfei Chen, Hao Yang

|Aug 07, 2025
The HBP Pathway Inhibitor FR054 Enhances Temozolomide Sensitivity in Glioblastoma Cells by Promoting Ferroptosis and Inhibiting O-GlcNAcylation.

Rongxu Ye, Wanghao Zhang, Huayang Zhang

|Feb 11, 2024
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.

Shanqiang Qu, Rongyang Xu, Guozhong Yi

|Dec 13, 2023
An integrated analysis of C5AR2 related to malignant properties and immune infiltration of gliomas.

Chengying Huang, Ouwen Qiu, Chaofu Mao

|Dec 13, 2023
The antiferroptotic role of TRIM7: Molecular mechanism and synergistic effect with temozolomide.

Luyao Wang, Rongyang Xu, Chengying Huang

Pageof 3

Frequent Collaborators

4 joint publications

Guanglong Huang

2 joint publications

Qiuming Pan

2 joint publications

Huafu Wang

2 joint publications

Songtao Qi